Related Experiment Video
Updated: Jul 19, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Methodological issues with adaptation of clinical trial design
H M James Hung1, Sue-Jane Wang, Robert T O'Neill
1Division of Biometrics I, OB/CDER/FDA, 10903 New Hampshire Avenue, BLDG 22 Rm 4238, HFD-710, Mail Stop 4105, Silver Spring, MD 20993-0002, USA. hsienming.hung@fda.hhs.gov
Pharmaceutical Statistics
|November 4, 2006
Summary
Adaptive clinical trial designs offer flexibility but present methodological challenges. Pre-specifying adaptation rules and carefully considering changes to hypotheses are crucial for practical and statistically sound clinical trials.
Area of Science:
- Clinical Trials
- Biostatistics
- Medical Research Methodology
Background:
- Clinical trial designs are increasingly adapted using interim data, posing unresolved methodological challenges.
- Statistical methodology for adaptive trials has advanced, but practical implementation issues persist.
Purpose of the Study:
- To address key methodological issues in adaptive clinical trial design.
- To evaluate different approaches to sample size re-estimation and hypothesis modification.
- To provide insights into practical considerations for adaptive trial planning.
Main Methods:
- Comparison of adaptive versus non-adaptive sample size re-estimation methods.
- Analysis of power advantages for primary endpoint selection strategies.
- Evaluation of power improvements when dropping treatment arms.
Main Results:
- Adaptive sample size re-estimation methods are contrasted with corrected critical value approaches.
- Switching primary endpoints based on interim data offers limited power advantage over Bonferroni adjustment.
- Discontinuing a treatment arm and reallocating its sample size significantly boosts power for identifying superior treatments.
Conclusions:
- Pre-specification of adaptation rules is vital for the practicality of adaptive clinical trials.
- Modifying trial hypotheses using interim data raises significant concerns among researchers.
- Careful planning and rule pre-specification are essential for successful adaptive trial implementation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...